Your Comprehensive Guide to Analytical Testing, From Clinical to Commercial

The life science industry has been growing rapidly, primarily driven by the rise of aging population and innovation in new modalities. As a result, many biopharma companies are choosing to outsource their analytical method development and testing to CDMOs in order to fully meet their objectives and foster innovation in creating effective treatments.

The question is – with most CDMOs offering analytical testing services, how can you be sure you have chosen the ideal partner for your organization? Join us for this insightful discussion for a look at:

• Real-life experiences from both a biopharma and CDMO perspective
• What a true partnership should deliver
• The importance of selecting a partner with a robust track record and in-depth scientific expertise, and what can be done to ensure this
• How a CDMO can help biopharma address specific project needs, such as early phase clinical development, late phase or commercial products, small molecules, and biologics or advanced modalities
• And more

Request Free!